Data About Zetia Risks Was Not Fully Revealed
New York Times
By ALEX BERENSON
Published: December 21, 2007
New evidence shows that the drug makers Merck and Schering-Plough have conducted several studies of their popular cholesterol medicine Zetia that raise questions about its risks to the liver, but the companies have never published those results.
The entire article can be found here.
*http://www.nytimes.com/2007/12/21/business/21drug.html